The results showed that UBE2C, PTTG1, TOP2A and SPP1 were positive, FCN3, SLC22A1, ADH4, CYP2C8, SLC10A1, and FBP1 were negative in liver cancer tissues (Fig. 2G). This evidence concerns the gene ADH4 and liver cancer.